Intercept Pharmaceuticals' stock set to soar after Alfasigma buyout deal for an 82% premium
Shares of Intercept Pharmaceuticals Inc. were set to soar Tuesday, after the biopharmaceutical company announced an agreement to be acquired by Italy’s...
Stay updated with breaking news from Jerry Durso. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Intercept Pharmaceuticals Inc. were set to soar Tuesday, after the biopharmaceutical company announced an agreement to be acquired by Italy’s...
The acquisition will help boost Alfasigma’s gastroenterology and hepatology pipeline, all while giving it access to Intercept’s lead candidate Ocaliva.
Some on Wall Street are betting that these troubled stocks will keep falling.
Operator: Hello, and thank you for standing by. Welcome to Intercept Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
The FDA has issued a CRL to Intercept Pharmaceuticals regarding the NDA for obeticholic acid for pre-cirrhotic fibrosis due to NASH.